The Importance of Sialo-Containing Glycans in Cell Biology
==========================================================

All living cells possess a complex and dense coating composed of glycoconjugates ([@B92]). Such structures exist as glycolipids, glycoproteins, and proteoglycans. Among other functions, cell surface glycans mediate cell--cell recognition and control interactions between cells and other components in their local environment. Throughout evolution, glycans were designated several roles based on their physical features and structural diversity ([@B93]). Advances in glycobiology researches have provided the means to correlate glycan structures to physiological and pathological conditions ([@B40]; [@B5]; [@B78]; [@B37]; [@B80]). The result is that glycoscience is emerging as a major contributor to the understanding of biology and medicine. The functional specificity of glycans is often dictated by the monosaccharides at the outermost ends of glycan chains ([@B6]; [@B92]; [@B34]). In mammals, the glycan chain of glycoproteins and glycolipids often end with sialic acids (Sia), a group of sugars with distinctive chemical properties that determine their functions ([@B87]). Discovered about 70 years ago, Sia is a generic term referring to nine-carbon alpha (α)-keto sugars with a carboxyl group linked directly to the ring as well as its *N* or *O* substituted derivatives. There are over 50 Sia described, while the two most commonly found in mammals are *N*-acetyl and *N*-glycolyl neuraminic acid ([@B96]). It is estimated that a cell exhibits tens of millions Sia molecules, with the concentration in the glycocalyx approaching 100 mM ([@B95]). Thanks to its bulky size and the electron density of the carboxyl group, Sia provides an important source of negative charge, which could alter the biophysical properties of cellular interactions. In eukaryotic cells, Sia residues are responsible for mediating many important interactions, including but not limited to regulation of transmembrane receptor function, altering membrane transport, control of glycoproteins (and even cell) half-life ([@B72]). One of the most notable functions of Sia is to regulate immune response, playing an important role in self and non-self recognition ([@B87]). It should not come as a surprise that several pathogenic microorganisms, such as viruses, bacteria, and protozoa have evolved strategies to exploit this feature ([@B52]; [@B53]; [@B14]). One of the more stylish mechanisms of cell surface sialylation is exploited by the protozoal *Trypanosoma cruzi*, the etiological agent of Chagas disease ([@B62]; [@B99]; [@B76], [@B77]; [@B49]; [@B50]).

*Trypanosoma cruzi trans*-Sialidase and Host Cell Invasion
==========================================================

Incapable of synthetizing Sia, *T. cruzi* has developed an elegant mechanism to take advantage of the Sia residues displayed in its mammalian host sialoglycans in order to avoid detection and elimination by immune cells ([@B59]; [@B21]; [@B28]). Since it was shown that *T. cruzi* could not use the activated monosaccharide precursor CMP-Neu5Ac, as it was first considered ([@B73]), it was proposed a novel metabolic mechanism of *trans*-glycosylation, by which *T. cruzi* would incorporate Sia onto its own cell surface ([@B62]). Incorporation of Sia on the surface molecules of *T. cruzi* parasite is catalyzed by the enzyme called *trans*-sialidase (Tc-TS) [@B62]; [@B76]). It was demonstrated *in vitro* and *in vivo* ([@B99]; [@B61]) the activity of Tc-TS was characterized as specific for α-2,3 Sia, being responsible for the transfer of Sia residues from the mammal host surface sialylated molecules to the parasite mucin-like acceptors ([@B76]; [@B56]; [@B70]; [@B63]).

In *T. cruzi*, the relevance of the acquisition of Sia is not completely known. However, there are proposals that such an event might help trypomastigote forms adhere and penetrate into non-phagocytic cells ([@B45]; [@B74]). Sia also provides a strong negatively charged cover that protects parasites against human lytic antibodies specific for α-galactosyl residues present on the trypomastigote surface ([@B58]).

The transfer of a Sia residue onto an acceptor hinders the access of a second residue when two potential acceptor sites are present on the same oligosaccharide ([@B64]). Tc-TS can also operate as a viral and bacterial sialidase, irreversibly transferring Sia to water in the absence of a carbohydrate acceptor ([@B91]). Analysis of the crystal structure revealed that the molecular architecture of the Tc-TS active site preserves numerous conserved features of microbial sialidases ([@B10]). Furthermore, all sialidases studied so far, including Tc-TS, catalyze sialoside hydrolysis with configuration retention ([@B85]).

There has been significant progress in understanding the importance of Tc-TS on the biology of *T. cruzi*. However, obstacles such as the lack of knockout strains, as well as the absence of specific Tc-TS inhibitors pose difficulties for the progress in the area. In regard to the Tc-TS inhibitors, many of them are not strong enough to serve as a scaffold to the development of drug targeting Tc-TS. In addition, most are derivatives of the substrate Sia or a transition state analog known as 2,3-dehydro-3-deoxy-*N*-acetylneuraminic acid (DANA), with *in vitro* IC(50) values near the milimolar range and low *in vivo* efficacy ([@B90]; [@B2]; [@B4]; [@B21]). Recent studies suggest that high affinity inhibitory monoclonal antibodies (mAb) for Tc-TS might provide a rational framework for novel approaches in the design of chemotherapeutic drugs ([@B11]).

Over the last years, several papers described by Campetella's group demonstrated that active Tc-TS (aTS) induces systemic effects during the acute phase of the disease ([@B47], [@B48]; [@B88]; [@B68]; [@B69]), until the elicitation of broad neutralizing antibodies ([@B60]). [@B11] reported the identification and detailed characterization of the neutralizing mouse mAb 13G9, which was able to recognize and inhibit Tc-TS with high specificity. The crystal structure of the complex involving the antigen-binding fragment and the globular region of Tc-TS demonstrated that not obstructing the enzyme's catalytic site, the antibody inhibited the movement of an assisting tyrosine (Y~119~), which plays an important role in the *trans*-glycosidase mechanism ([@B10]). The authors suggest that such results may bring into light new strategies for chemotherapy in Chagas disease and for disclosure of aTS function in *T. cruzi* pathogenesis and biology.

Besides encoding aTS, the genes of the TS family also encode its inactive analog (iTS). iTS has a His at position 342, while active members contain a Tyr at the same position ([@B16]; [@B23]). It has been suggested that iTS may mediate the initial contact between *T. cruzi* and host cells, functioning as an adhesin that contains two sugar-binding distinct sites, for Sia and β-galactose ([@B83]). Recently, [@B69] demonstrated that both aTS and iTS besides to induce a Th2-like phenotype in naive T cells, also compromise the emergence of Th1 cells. Additionally, both isoforms were associated with the parasite's ability to reduce IL-2 production and IL-2Ra expression by T cells. The authors suggest that TS proteins are able to manipulate the TCD4^+^ response throughout their maturation stages to favor parasite survival and infection.

The bivalent nature of iTS could promote a glycan cross-linking believed to be essential for cellular signal transduction. Tc-TS has essentially two different domains. The N-terminal, which contains the catalytic domain of the enzyme ([@B67]), and the C-terminal, which is composed basically of 12 amino acids-long units repeated in tandem, termed SAPA (shed acute-phase antigen; [@B1]), which is not required for TS activity ([@B12]). Tc-TS is linked to the parasite membrane via glycosylphosphatidylinositol (GPI) anchor and shed into the bloodstream during the infection ([@B75]). Nowadays, it is well recognized that Tc-TS is an important virulence factor involved in cell invasion and pathogenesis of Chagas disease ([@B43]; [@B21]; [@B44]; [@B28]). However, the studies regarding the importance of Tc-TS for cell invasion and parasite survival were paramount to understanding how *T. cruzi* is capable of subverting the immune system by disturbing the host cells sialoglycophenotype.

Roles of Sialic Acids on T Cell Biology
=======================================

It is well documented that in T cells, different lectin families recognize distinct sialylated ligands on glycoproteins or glycolipids to regulate their functions ([@B65],[@B66]; [@B39]; [@B17]; [@B18]). Examples include siglecs, a family of Sia-binding lectins that belong to the superfamily of I-type lectins ([@B18]). Most siglecs bind α-2,3 and/or α-2,6-linked Sia on penultimate Gal residues on cell surface glycoproteins or glycolipids; however, some members bind to repeating Sia chains ([@B94]). In the immune system, siglecs mainly function as controllers of cell signaling, although roles for some siglecs in pathogen recognition and innate immunity have been proposed ([@B97]). [@B24] demonstrated that sialylated ligands on *T. cruzi* interact with Siglec-E (sialic acid-binding Ig-like lectin-E) on dendritic cells (DC), and such interaction suppressed the production of the proinflammatory cytokine IL-12 and subsequent T cell activation. Recently, it was proposed that sulfates from cruzipain, another important antigen expressed by *T. cruzi*, might play an essential role in the interaction with Siglec-E on inflammatory cells, favoring the persistence of the parasite in its mammalian hosts ([@B25]).

Sia plays crucial roles in the regulation of host immunity, as evidenced by the sialylation changes sustained by naïve T cells during thymic selection, a tightly regulated process, essential for establishing central tolerance ([@B19]; [@B46]; [@B13]; [@B57]). The alterations suffered on cell surface *N*- and *O*-linked glycans, including glycoprotein sialylation, during T cell development and differentiation ([@B20]) might regulate the T cell response through a direct effect on the intrinsic properties of specific proteins, or by modulating the binding of a disparate set of cell surface proteins to a specific carbohydrate moiety. It is important to bring out that many of the changes in the degree of sialylation of carbohydrate chains observed in T cells during their development can be monitored with plant lectins ([@B79]; [@B20]). It has been shown *in vitro* and *in vivo* that T cell activation is accompanied by loss of Sia from core 1 *O*-glycans (Siaα2,3Galβ1,3GalNAc-Ser/Thr; [@B30]; [@B8]), which leads to exposure of asialo core 1 *O*-glycans. Such residues can be detected with the plant lectin peanut agglutinin (PNA), that recognizes Galβ1,3GalNAc sequences on several glycoproteins including CD8, CD43, and CD45 ([@B98]). It is a known fact that the loss of cell-surface Sia during T cell activation enhances TCR reactivity with antigens ([@B30]; [@B33]; [@B8]). Indeed, T cell cytolytic activity may be boosted by sialidase treatment, with a simultaneous reduction in cell surface negative charge ([@B71]). In addition, de-sialylated CD8^+^ T cells undergo more rounds of cell division following contact with antigen ([@B55]). Recognition and disposal of pathogens rely upon the concerted actions of adaptive and innate immunological mechanisms, including recruitment of different cell types as well as production and release of cytokines, antibodies or other effector molecules ([@B35]). In regards to adaptive response, while the importance of CD8^+^ T cells is well described when it comes to the control of several viral and bacterial infections, it is seldom mentioned that eukaryotic pathogens, such as protozoans, are also subject to the action of cytotoxic lymphocytes. Chagas disease is probably the most well understood example of the role CD8^+^ T cells play during protozoan infections. In its vertebrate hosts, *T. cruzi* is perpetually changing between its intracellular amastigote forms and extracellular trypomastigote ones. There is a great range of cells that are subject to invasion by the parasite, including but not limited to fibroblasts, macrophages, myocytes, and adipocytes. During the intracellular stages, *T. cruzi* antigens are presented by antigen presenting cells (APCs) through by MHC class I molecules, providing many opportunities for detection by CD8^+^ T cells ([@B31]). Several reports confirmed the importance of CD8^+^ T cell cytotoxicity regarding Chagas disease ([@B81], [@B82]; [@B54]; [@B22]). One of the most important was the identification of a number of epitopes expressed in proteins belonging to the TS family genes ([@B42]). Until that point, there was a lack of immunodominant T cell epitopes, but now it is accepted that members of the TS gene family are a good target for CD8^+^ T cells. That discovery has not only led to a better understanding of how the immune system reacts to *T. cruzi* infection, but in a more practical venue has also fueled the research on vaccine development ([@B41]; [@B3]; [@B9]). Although it is universally accepted that CD8^+^ T cell response is an important factor in mediating host survival during *T. cruzi* infection, there is a substantial delay in the appearance of antigen specific CD8^+^ T cells following infection ([@B42]; [@B89]). This delay differs from the quick response of CD8^+^ T cells in other bacterial, viral, and, even protozoal infections ([@B36]), suggesting that a mechanism of immune subversion is operative.

*Trypanosoma cruzi trans*-Sialidase Modulates T Cell Sialoglycophenotype
========================================================================

As mentioned above, Sia content of T cell glycoproteins and glycolipids is regulated during both T cell development in the thymus and activation in the periphery ([@B46]; [@B55]). Each T cell subset expresses a specific set of glycan-modifying enzymes that regulate the pattern of sialylation on the cell surface ([@B8]). Besides being able to sialylate mucin-like molecules expressed on the parasite surface, Tc-TS is also capable of re-sialylating host cell asialoglycoconjugates ([@B49]). Regarding T cells, such event is able to modulate both their function and half-life. Several papers published elsewhere have demonstrated that alterations in Sia residues on thymocytes and mature T cells are able to induce apoptosis ([@B38]; [@B47], [@B48], [@B49]). Given the way TS works, it comes as a logical conclusion that the parasite's ability to modulate the T cell sialophenotype is a powerful tool in evading detection and elimination by the host immune system. Pioneering studies on the impact of Tc-TS on T cells ([@B15]) demonstrated that intravenous injection of minute amounts of native Tc-TS was able to increase the parasitemia and mortality of *T. cruzi*-infected mice. The authors suggested that such effects were entirely dependent on Tc-TS activity, since the same events did not occur in mice primed with viral or bacterial sialidases. Further *in vitro* experiments demonstrated that recombinant Tc-TS binds host T-lymphocytes, activating CD4^+^ T cells through CD43 engagement ([@B84],[@B86]). However, molecular evidences revealed that CD45 might be the main acceptor of Tc-TS during *T. cruzi* infection ([@B50]). *In vivo* studies have highlighted the impact of Tc-TS on B and T cells sialoglycophenotypes ([@B27]; [@B7]), reinforcing the idea that the Tc-TS may act as a virulence factor during *T. cruzi* infection. In B cells, the sialylation of cell surface molecules by Tc-TS elicits the production of IL-17. Interestingly, such event triggers a signaling pathway that differs from the one classically associated with IL-17, bypassing the activation of RORγt and RORα ([@B7]). As for T cells, [@B27] demonstrated the relevance of Tc-TS on the sialoglycophenotype of splenic CD8^+^ T cells during *T. cruzi* infection. *T. cruzi*-infected or *Plasmodium berghei*-infected mice were sacrificed on the eighth day post-infection (dpi), and the sialoglycophenotype of CD8^+^ T cells was assessed. As expected, CD8^+^ T cells from *P. berghei*-infected mice were highly positive for PNA (PNA^high^). Interestingly, the glycophenotype PNA intermediate (PNA^int^) exhibited by CD8^+^ T cells derived from *T. cruzi*-infected mice, becomes PNA^low^ after intravenous administration recombinant aTS. Such event was able to inhibit the cytotoxic response mediated by antigen specific CD8^+^ T cells, supporting the idea that re-sialylation of asialoglycans on the surface of activated T cells might be a sophisticated evasion mechanism adopted by *T. cruzi* to subvert the host immune response ([@B27]). In addition, we found that CD8^+^ T cells from *T. cruzi*-infected mice primed with recombinant iTS exhibited a glycophenotype PNA^high^, suggesting that iTS might have been able to compete with the native aTS by serum sialoglycoproteins, compromising the expected event of re-sialylation that takes place during the acute phase of Chagas disease ([@B27]). Although the evidence is quite compelling, new experiments with ST3 Gal-I KO mice must be conducted in order to understand the effects triggered by Tc-Ts on CD8^+^ T cells during *T. cruzi* infection. Several immunobiological effects mediated by Tc-TS have been described elsewhere ([@B49]; [@B69]), but the chemical evidence of the enzyme's essential role in the parasite is still lacking due to the absence of specific inhibitors of Tc-TS. As it stands Tc-TS is a promising target in drug design, an area in which further research is urgently needed.

Conclusion
==========

Over the last years, several papers have demonstrated the importance of differential sialylation for CD8^+^ T cells with respect to their maturation ([@B46]; [@B51]), activation ([@B55]), and cytotoxic responses ([@B71]). However, few studies provided insights into the impact of surface sialylation of CD8^+^ T cells on infectious diseases. Infection with *T. cruzi* is of particular interest in this context because the parasite releases into the host plasma large amounts of proteins belonging to the TS family ([@B26]; [@B75]; [@B32]; [@B29], [@B28]). Recent studies demonstrated that cell surface asialoglycans on B and T lymphocytes might be sialylated by the action of Tc-TS ([@B27]; [@B7]). Such events were able to disturb the host immune response and allow for the continuation of the parasite in the infected host. Since it is universally accepted that Tc-TS acts as a virulence factor during *T. cruzi* infection, further efforts are needed in this lively area to better understand the catalytic mechanism, as well as the functional properties of the Sia-dependent enzyme. Certainly, new impacting findings will contribute to further research on the enzyme as a therapeutic target in the fight against Chagas' disease.
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